Item Type | Name |
Concept
|
Ambulatory Care
|
Concept
|
Intensive Care Units
|
Concept
|
Intensive Care Units, Neonatal
|
Concept
|
Patient Acceptance of Health Care
|
Concept
|
Patient Care Planning
|
Concept
|
Primary Health Care
|
Concept
|
Self Care
|
Concept
|
Intensive Care, Neonatal
|
Concept
|
Treatment Refusal
|
Concept
|
Treatment Outcome
|
Concept
|
Treatment Failure
|
Concept
|
Delivery of Health Care, Integrated
|
Academic Article
|
Treatment of hypertensive crisis.
|
Academic Article
|
Incidence, significance, and kinetic mechanism responsible for leukemoid reactions in patients in the neonatal intensive care unit: a prospective evaluation.
|
Academic Article
|
Recent advances in the pathogenesis and treatment of nonimmune neutropenias in the neonate.
|
Academic Article
|
Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic patients in a neonatal intensive care unit.
|
Academic Article
|
Interaction between lifetime captopril treatment and NaCI-sensitive hypertension in spontaneously hypertensive rats and Wistar-Kyoto rats.
|
Academic Article
|
Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial.
|
Academic Article
|
"Idiopathic neutropenia" in very low birthweight infants.
|
Academic Article
|
Human developmental biology of granulocyte colony-stimulating factor.
|
Academic Article
|
A practical approach to evaluating and treating neutropenia in the neonatal intensive care unit.
|
Academic Article
|
Eosinophilia in the neonatal intensive care unit.
|
Academic Article
|
Consistent approaches to procedures and practices in neonatal hematology.
|
Academic Article
|
Stability of filgrastim and epoetin alfa in a system designed for enteral administration in neonates.
|
Academic Article
|
Immune-mediated neutropenia in the neonate.
|
Academic Article
|
Efficacy of low-dose spironolactone in subjects with resistant hypertension.
|
Academic Article
|
Resistant or difficult-to-treat hypertension.
|
Academic Article
|
Use of aldosterone antagonists in resistant hypertension.
|
Academic Article
|
Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension.
|
Academic Article
|
Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
|
Academic Article
|
Primary aldosteronism: diagnosis and treatment.
|
Academic Article
|
Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertension.
|
Academic Article
|
Mechanisms and treatment of resistant hypertension.
|
Academic Article
|
Improving blood pressure control: increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? the valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trial.
|
Academic Article
|
2008 American Heart Association Statement on diagnosis, evaluation, and treatment of resistant hypertension: what should we remember in everyday practice?
|
Academic Article
|
Sleep apnea, aldosterone, and resistant hypertension.
|
Academic Article
|
Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.
|
Academic Article
|
Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.
|
Academic Article
|
Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
|
Academic Article
|
Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: a losartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy.
|
Academic Article
|
Resistant hypertension and hyperaldosteronism.
|
Academic Article
|
Aldosterone and cardiovascular disease.
|
Academic Article
|
Resistant hypertension: who and how to evaluate.
|
Academic Article
|
Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
|
Academic Article
|
Characterization and treatment of resistant hypertension.
|
Academic Article
|
Current options for the treatment of resistant hypertension.
|
Academic Article
|
Obstructive sleep apnea and hypertension.
|
Academic Article
|
Reduction of blood pressure in patients with treatment-resistant hypertension.
|
Academic Article
|
Treatment of resistant hypertension.
|
Academic Article
|
Effectiveness of initiating treatment with valsartan/hydrochlorothiazide in patients with stage-1 or stage-2 hypertension.
|
Academic Article
|
Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report.
|
Academic Article
|
Resistant hypertension, secondary hypertension, and hypertensive crises: diagnostic evaluation and treatment.
|
Academic Article
|
Treatment of resistant hypertension.
|
Academic Article
|
Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension.
|
Academic Article
|
Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial.
|
Academic Article
|
Refractory hypertension: definition, prevalence, and patient characteristics.
|
Academic Article
|
Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
|
Academic Article
|
Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease.
|
Academic Article
|
Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diuretics.
|
Academic Article
|
Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients.
|
Academic Article
|
Recent advancements in the treatment of resistant hypertension.
|
Academic Article
|
Resistant hypertension and aldosterone: an update.
|
Academic Article
|
Blood pressure and treatment of persons with hypertension as it relates to cognitive outcomes including executive function.
|
Academic Article
|
Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension.
|
Academic Article
|
Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.
|
Academic Article
|
Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort.
|
Academic Article
|
Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.
|
Academic Article
|
Prevalence of apparent treatment-resistant hypertension among individuals with CKD.
|
Academic Article
|
Apparent and true resistant hypertension: why not the same?
|
Academic Article
|
Characteristics of resistant hypertension in a large, ethnically diverse hypertension population of an integrated health system.
|
Academic Article
|
Management of patients with resistant hypertension: current treatment options.
|
Academic Article
|
Response to Comment on optimal treatment for resistant hypertension: the missing data on pulse wave velocity.
|
Academic Article
|
Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: the Reasons for Geographic and Racial Differences in Stroke study.
|
Academic Article
|
Effects of the once-weekly glucagon-like peptide-1 receptor agonist dulaglutide on ambulatory blood pressure and heart rate in patients with type 2 diabetes mellitus.
|
Academic Article
|
Characterizing workers participating in a worksite wellness health screening program using blood pressure control, self-monitoring, medication adherence, depression, and exercise.
|
Academic Article
|
Effect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy.
|
Academic Article
|
Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
|
Academic Article
|
Pathophysiology and treatment of resistant hypertension: the role of aldosterone and amiloride-sensitive sodium channels.
|
Academic Article
|
Detection, evaluation, and treatment of severe and resistant hypertension: proceedings from an American Society of Hypertension Interactive forum held in Bethesda, MD, U.S.A., October 10th 2013.
|
Academic Article
|
Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT.
|
Academic Article
|
Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.
|
Academic Article
|
Results of an Academic, Health Care Worksite Weight Loss Contest for Southeastern Americans: Scale Back Alabama 2011-2013.
|
Academic Article
|
Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.
|
Academic Article
|
Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension.
|
Academic Article
|
Refractory Hypertension: Evidence of Heightened Sympathetic Activity as a Cause of Antihypertensive Treatment Failure.
|
Academic Article
|
Resistant and Refractory Hypertension: Antihypertensive Treatment Resistance vs Treatment Failure.
|
Academic Article
|
Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status.
|
Academic Article
|
Do We Need a New Definition of Hypertension After SPRINT?
|
Academic Article
|
Comparisons of sleep apnoea rate and outcomes among patients with resistant and non-resistant hypertension.
|
Academic Article
|
Use of Aldosterone Antagonists for Treatment of Uncontrolled Resistant Hypertension.
|
Academic Article
|
Effects of Spironolactone and Renal Denervation Treatment on Blood Pressure and Its Variability-Different Aspects of Hypertension Treatment.
|
Academic Article
|
Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure.
|
Academic Article
|
Spironolactone versus renal nerve denervation for treatment of uncontrolled resistant hypertension.
|
Academic Article
|
Refractory and Resistant Hypertension: Antihypertensive Treatment Failure versus Treatment Resistance.
|
Academic Article
|
Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT.
|
Academic Article
|
11-Beta Dehydrogenase Type 2 Activity Is Not Reduced in Treatment Resistant Hypertension.
|
Academic Article
|
National patterns in intensity and frequency of outpatient care for apparent treatment-resistant hypertension.
|
Academic Article
|
Distinctive Risk Factors and Phenotype of Younger Patients With Resistant Hypertension: Age Is Relevant.
|
Academic Article
|
Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea.
|
Academic Article
|
The association of nocturnal hypertension and nondipping blood pressure with treatment-resistant hypertension: The Jackson Heart Study.
|
Academic Article
|
Fluid retention, aldosterone excess, and treatment of resistant hypertension.
|
Academic Article
|
Early feasibility of hypoglossal nerve upper airway stimulator in patients with cardiac implantable electronic devices and continuous positive airway pressure-intolerant severe obstructive sleep apnea.
|
Academic Article
|
Maternal and neonatal demographics of macrosomic infants admitted to the neonatal intensive care unit.
|
Academic Article
|
Medical Versus Surgical Treatment of Primary Aldosteronism.
|
Academic Article
|
Optimal Systolic Blood Pressure Target in Resistant and Non-Resistant Hypertension: A Pooled Analysis of Patient-Level Data from SPRINT and ACCORD.
|
Academic Article
|
Resistant Hypertension: An Update.
|
Academic Article
|
Out-of-Clinic Sympathetic Activity Is Increased in Patients With Masked Uncontrolled Hypertension.
|
Academic Article
|
Prevalence of Apparent Treatment-Resistant Hypertension in the United States.
|
Academic Article
|
The ACC/AHA and ESC/ESH Hypertension Guidelines: Contrasting Versions of Idiosyncratic Excellence.
|
Academic Article
|
Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence.
|
Academic Article
|
Treatment of Resistant and Refractory Hypertension.
|
Academic Article
|
Reserpine Substantially Lowers Blood Pressure in Patients With Refractory Hypertension: A Proof-of-Concept Study.
|
Academic Article
|
Apparent treatment-resistant hypertension: characteristics and prevalence in a real-world environment of an integrated health system.
|
Academic Article
|
Case of Episodic and Positional Hypertension: Diagnosis and Treatment.
|
Academic Article
|
Underutilization of Treatment for Black Adults With Apparent Treatment-Resistant Hypertension: JHS and the REGARDS Study.
|
Academic Article
|
Effect of Serum Urate Lowering With Allopurinol on Blood Pressure in Young Adults: A Randomized, Controlled, Crossover Trial.
|